NCT06884280View on ClinicalTrials.gov

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Peritoneal DialysisAnaemiaIron Deficiency, Anaemia
Interventions
DRUG

Monofer (iron isomaltoside 1000)

Intravenous iron infusion, administered in this study up to every 3 months. Dosage determined by haemoglobin and weight.

DRUG

Ferrous Sulfate

Oral iron tablet taken once daily for duration of study.

Trial Locations (1)

HU3 2JZ

Hull University Teaching Hospitals NHS Trust, Hull

Sponsors
All Listed Sponsors
collaborator

Pharmacosmos Therapeutics, Inc.

UNKNOWN

lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT06884280 - Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study | Biotech Hunter | Biotech Hunter